Article
Implication of alternative splicing for expression of a variant NAD(P)H:quinone oxidoreductase-1 with a single nucleotide polymorphism at 465C>T.
Pharmacogenetics - 1 Aug 2002
Pan Su-Shu, Han Yusheng, Farabaugh Philip, Xia Hong
Abstract excerpt
Three alleles of the human reduced nicotinamide adenine dinucleotide phosphate:quinone oxidoreductase-1 (NQO1) gene are known; wild-type, 609C>T variant, and 465C>T variant; designated as NQO1*1 and NQO1*2, and NQO1*3, respectively. Previously, we found NQO1*3 in one allele of HCT-116 cells, and in both alleles of the mitomycin C-resistant subline, HCT-116R30A. The NQO1 protein content of HCT-116R30A is 5% that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
